VisionCare’s FDA Approved Telescope Gets Implanted
VisionCare’s lead product, Implantable Miniature Telescope by Dr. Isaac Liphitz, enlarges images in front of the eye approximately 2.5 times their normal size.
amd
NeoVista’s Macular Degeneration Device Improves Visual Acuity in Yearlong Study
Medical device company NeoVista, Inc., recently announced 12-month results from its MERITAGE study in patients with wet age-related macular degeneration, a leading cause of vision loss in older Americans.
NeoVista’s Sights Remain On Underserved AMD Market
The administration of the device plus the administration of as-needed anti-VEGF therapy is showing promising results.
FDA Approves Implantable Telescope for the Eye
The U.S. Food and Drug Administration has approved the first implantable eye telescope to improve vision in patients with end-stage age-related macular degeneration.
[OneMedForum] MacuCLEAR Sees Unmet Need for Vision-Loss Treatment
With the large Baby Boomer population reaching its senior years, the incidence of age-related vision loss in the U.S. is expected to increase.
[Company Profile] NeoVista
The company is focused on the development of medical technologies that to treat wet age-related macular degeneration (AMD).